• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种二聚体正向调节剂桥接两个相同的AMPA受体结合位点的结构证明。

Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.

作者信息

Kaae Birgitte H, Harpsøe Kasper, Kastrup Jette S, Sanz Alberto Contreras, Pickering Darryl S, Metzler Bjørn, Clausen Rasmus P, Gajhede Michael, Sauerberg Per, Liljefors Tommy, Madsen Ulf

机构信息

Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

出版信息

Chem Biol. 2007 Nov;14(11):1294-303. doi: 10.1016/j.chembiol.2007.10.012.

DOI:10.1016/j.chembiol.2007.10.012
PMID:18022568
Abstract

Dimeric positive allosteric modulators of ionotropic glutamate receptors were designed, synthesized, and characterized pharmacologically in electrophysiological experiments. The designed compounds are dimers of arylpropylsulfonamides and have been constructed without a linker. The monomeric arylpropylsulfonamides were derived from known modulators and target the cyclothiazide-binding site at the AMPA receptors. The three stereoisomers--R,R, meso, and S,S--of the two constructed dimers were prepared, and in vitro testing showed the R,R forms to be the most potent stereoisomers. The biarylpropylsulfonamides have dramatically increased potencies, more than three orders of magnitude higher than the corresponding monomers. Dimer (R,R)-2a was cocrystallized with the GluR2-S1S2J construct, and an X-ray crystallographic analysis showed (R,R)-2a to bridge two identical binding pockets on two neighboring GluR2 subunits. Thus, this is biostructural evidence of a homomeric dimer bridging two identical receptor-binding sites.

摘要

离子型谷氨酸受体的二聚体正变构调节剂在电生理实验中进行了设计、合成及药理学表征。所设计的化合物为芳基丙基磺酰胺二聚体,且构建时未使用连接子。单体芳基丙基磺酰胺衍生自已知调节剂,靶向AMPA受体的环噻嗪结合位点。制备了两种构建的二聚体的三种立体异构体——R,R、内消旋体和S,S,体外测试表明R,R形式是最有效的立体异构体。联芳基丙基磺酰胺的效力显著提高,比相应单体高出三个多数量级。二聚体(R,R)-2a与GluR2-S1S2J构建体共结晶,X射线晶体学分析表明(R,R)-2a桥接两个相邻GluR2亚基上的两个相同结合口袋。因此,这是同聚二聚体桥接两个相同受体结合位点的生物结构证据。

相似文献

1
Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites.一种二聚体正向调节剂桥接两个相同的AMPA受体结合位点的结构证明。
Chem Biol. 2007 Nov;14(11):1294-303. doi: 10.1016/j.chembiol.2007.10.012.
2
Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.与(S)-谷氨酸结合的红藻氨酸受体GluR5配体结合核心的晶体结构。
FEBS Lett. 2005 Feb 14;579(5):1154-60. doi: 10.1016/j.febslet.2005.01.012.
3
Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.酪氨酸702是谷氨酸受体2(GluR2)配体结合核心激动剂结合和结构域关闭的重要决定因素。
Mol Pharmacol. 2005 Mar;67(3):703-13. doi: 10.1124/mol.104.002931. Epub 2004 Dec 9.
4
Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity.与激动剂(S)-ATPA结合的GluR2配体结合核心的三维结构:对受体亚基选择性的影响
J Med Chem. 2003 Feb 27;46(5):872-5. doi: 10.1021/jm021020+.
5
Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.微秒到毫秒级的构象动力学区分了与激动剂谷氨酸、quisqualate和AMPA结合的GluR2谷氨酸受体。
Biochemistry. 2005 Mar 8;44(9):3410-7. doi: 10.1021/bi047984f.
6
Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.探究GluR2配体结合核心的功能、构象可塑性及二聚体-二聚体相互作用:5-取代威拉地丁与晶体中GluR2 S1S2的研究
Biochemistry. 2003 May 13;42(18):5201-13. doi: 10.1021/bi020632t.
7
Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.环噻嗪独特的结构特征是其对离子型谷氨酸受体2(iGluR2)的峰值电流幅度和脱敏动力学产生影响的原因。
J Mol Biol. 2009 Sep 4;391(5):906-17. doi: 10.1016/j.jmb.2009.07.002. Epub 2009 Jul 8.
8
Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotency.与激动剂(R)-和(S)-2-氨基-3-(4-羟基-1,2,5-噻二唑-3-基)丙酸复合的离子型谷氨酸受体2(iGluR2)配体结合核心结构解释了它们不同寻常的等效性。
J Med Chem. 2008 Mar 13;51(5):1459-63. doi: 10.1021/jm701126w. Epub 2008 Feb 13.
9
A stereochemical anomaly: the cyclised (R)-AMPA analogue (R)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-5-carboxylic acid [(R)-5-HPCA] resembles (S)-AMPA at glutamate receptors.一种立体化学异常现象:环化的(R)-AMPA类似物(R)-3-羟基-4,5,6,7-四氢异恶唑并[5,4-c]吡啶-5-羧酸[(R)-5-HPCA]在谷氨酸受体处类似于(S)-AMPA。
Org Biomol Chem. 2004 Jan 21;2(2):206-13. doi: 10.1039/b310450h. Epub 2003 Nov 24.
10
Molecular mechanism of agonist recognition by the ligand-binding core of the ionotropic glutamate receptor 4.离子型谷氨酸受体4配体结合核心识别激动剂的分子机制。
FEBS Lett. 2008 Dec 10;582(29):4089-94. doi: 10.1016/j.febslet.2008.11.005. Epub 2008 Nov 18.

引用本文的文献

1
Cooperative Free Energy: Induced Protein-Protein Interactions and Cooperative Solvation in Ternary Complexes.协同自由能:三元复合物中的诱导蛋白质-蛋白质相互作用和协同溶剂化作用
J Chem Theory Comput. 2025 Sep 9;21(17):8557-8570. doi: 10.1021/acs.jctc.5c00736. Epub 2025 Aug 20.
2
Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review.阳性AMPA和海人酸受体调节剂及其在中枢神经系统疾病中的治疗潜力:综述
Int J Mol Sci. 2025 Jul 4;26(13):6450. doi: 10.3390/ijms26136450.
3
Cryo-electron tomographic investigation of native hippocampal glutamatergic synapses.
冷冻电镜断层扫描研究天然海马谷氨酸能突触。
Elife. 2024 Nov 4;13:RP98458. doi: 10.7554/eLife.98458.
4
What Makes a Good Protein-Protein Interaction Stabilizer: Analysis and Application of the Dual-Binding Mechanism.什么造就了良好的蛋白质-蛋白质相互作用稳定剂:双重结合机制的分析与应用
ACS Cent Sci. 2023 Apr 14;9(5):969-979. doi: 10.1021/acscentsci.3c00003. eCollection 2023 May 24.
5
The action of Con-ikot-ikot toxin on single AMPA-type glutamate receptors.康伊可托毒素对单 AMPA 型谷氨酸受体的作用。
J Gen Physiol. 2022 May 2;154(5). doi: 10.1085/jgp.202112912. Epub 2022 Apr 4.
6
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.谷氨酸受体离子通道的结构、功能和药理学。
Pharmacol Rev. 2021 Oct;73(4):298-487. doi: 10.1124/pharmrev.120.000131.
7
Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations.制药商:基于可药性模拟的药效团建模和命中鉴定。
Protein Sci. 2020 Jan;29(1):76-86. doi: 10.1002/pro.3732. Epub 2019 Dec 4.
8
Druggability Simulations and X-Ray Crystallography Reveal a Ligand-Binding Site in the GluA3 AMPA Receptor N-Terminal Domain.药物模拟和 X 射线晶体学揭示 GluA3 AMPA 受体 N 端结构域的配体结合位点。
Structure. 2019 Feb 5;27(2):241-252.e3. doi: 10.1016/j.str.2018.10.017. Epub 2018 Dec 6.
9
Auxiliary subunits keep AMPA receptors compact during activation and desensitization.辅助亚基在 AMPA 受体的激活和脱敏过程中保持其结构紧凑。
Elife. 2018 Dec 6;7:e40548. doi: 10.7554/eLife.40548.
10
Activation and Desensitization Mechanism of AMPA Receptor-TARP Complex by Cryo-EM.基于冷冻电镜的AMPA受体-TARP复合物激活与脱敏机制
Cell. 2017 Sep 7;170(6):1234-1246.e14. doi: 10.1016/j.cell.2017.07.045. Epub 2017 Aug 17.